The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergilosis (IPA)

M Siemann1, M Koch-Dörfler

  • 1Pathologisch-Bakteriologisches Institut, Städtisches Krankrenhaus, Kiel, Germany.

Mycoses
|November 21, 2001
PubMed

Insights

This study evaluated the Aspergillus galactomannan enzyme-linked immunosorbent assay (ELISA) for diagnosing pulmonary aspergillosis. The ELISA showed promising sensitivity, especially in respiratory tract specimens, aiding in early detection of invasive fungal infections.

Area of Science:

  • Medical diagnostics
  • Clinical microbiology
  • Mycology

Background:

  • Pulmonary aspergillosis is a serious fungal infection, often difficult to diagnose.
  • Early and accurate detection is crucial for effective patient management.
  • The Aspergillus galactomannan antigen test is a valuable tool in diagnosing invasive aspergillosis.

Observation:

  • This study assessed the sensitivity of a sandwich enzyme-linked immunosorbent assay (ELISA) for detecting Aspergillus galactomannan.
  • Specimens included serum and respiratory tract samples from patients with various pulmonary diseases.
  • Patient groups comprised proven, probable, and unlikely invasive pulmonary aspergillosis, as well as Aspergillus colonization.

Findings:

  • The Platelia Aspergillus ELISA demonstrated high sensitivity in respiratory tract specimens (90% for proven IPA, 60% for probable IPA, 71% for colonization).
  • Serum sensitivity was lower (38% for proven IPA, 37% for probable IPA, 0% for colonization).
  • The ELISA detected 85% of Aspergillus species from positive respiratory cultures and 57% of culture-negative specimens from patients with proven aspergillosis or positive cultures.

Implications:

  • The Aspergillus galactomannan ELISA, particularly using respiratory tract specimens, can significantly improve the diagnosis of pulmonary aspergillosis.
  • This diagnostic tool aids in differentiating invasive aspergillosis from colonization and in managing patients with suspected fungal infections.
  • Further research may optimize the use of ELISA in conjunction with other diagnostic methods for comprehensive Aspergillus infection assessment.

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...